Magnetic resonance imaging-DRAGON score: 3-month outcome prediction after intravenous thrombolysis for anterior circulation stroke

Stroke

Volumn 44, Issue 5, 2013, Pages 1323-1328

  Turc, Guillaume ^a   Apoil, Marion ^a,b   Naggara, Olivier ^a   Calvet, David ^a   Lamy, Catherine ^a   Tataru, Alina M ^a   Méder, Jean François ^a   Mas, Jean Louis ^a   Baron, Jean Claude ^a   Oppenheim, Catherine ^a   Touzé, Emmanuel ^a  

^a CENTRE HOSPITALIER SAINTE ANNE   (France)

^b UNIVERSITÉ DE CAEN   (France)

Author keywords

magnetic resonance imaging; outcome; stroke, acute; thrombolysis

Indexed keywords

TISSUE PLASMINOGEN ACTIVATOR;

ARTICLE; BRAIN ISCHEMIA; CEREBROVASCULAR ACCIDENT; DIFFUSION WEIGHTED IMAGING; DRAGON SCORE; FEMALE; HUMAN; MAJOR CLINICAL STUDY; MALE; MIDDLE CEREBRAL ARTERY OCCLUSION; NUCLEAR MAGNETIC RESONANCE IMAGING; PREDICTIVE VALIDITY; PRIORITY JOURNAL; RANKIN SCALE; SCORING SYSTEM; TREATMENT OUTCOME; VALIDATION STUDY;

ADMINISTRATION, INTRAVENOUS; AGED; AGED, 80 AND OVER; BRAIN; BRAIN ISCHEMIA; FEMALE; FIBRINOLYTIC AGENTS; FOLLOW-UP STUDIES; HUMANS; MAGNETIC RESONANCE IMAGING; MALE; PREDICTIVE VALUE OF TESTS; PROGNOSIS; STROKE; THROMBOLYTIC THERAPY; TISSUE PLASMINOGEN ACTIVATOR; TREATMENT OUTCOME;

EID: 84876824044     PISSN: 00392499     EISSN: 15244628     Source Type: Journal    
DOI: 10.1161/STROKEAHA.111.000127     Document Type: Article

References (22)

1. Rha JH, Saver JL. The impact of recanalization on ischemic stroke outcome: a meta-analysis. Stroke. 2007;38:967-973.
2. Wahlgren N, Ahmed N, Davalos A, Hacke W, Millan M, Muir K, et al. Thrombolysis with alteplase 3-4.5 h after acute ischaemic stroke (SITS-ISTR): an observational study. Lancet. 2008;372:1303-1309.
3. Vivien D, Gauberti M, Montagne A, Defer G, Touzé E. Impact of tissue plasminogen activator on the neurovascular unit: from clinical data to experimental evidence. J Cereb Blood Flow Metab. 2011;31:2119-2134.
4. Hacke W, Kaste M, Bluhmki E, Brozman M, Dávalos A, Guidetti D, et al.; ECASS Investigators. Thrombolysis with alteplase 3 to 4.5 hours after acute ischemic stroke. N Engl J Med. 2008;359:1317-1329.
5. Lees KR, Bluhmki E, von Kummer R, Brott TG, Toni D, Grotta JC, et al.; ECASS, ATLANTIS, NINDS and EPITHET rt-PA Study Group. Time to treatment with intravenous alteplase and outcome in stroke: an updated pooled analysis of ECASS, ATLANTIS, NINDS, and EPITHET trials. Lancet. 2010;375:1695-1703.
6. Strbian D, Meretoja A, Ahlhelm FJ, Pitkäniemi J, Lyrer P, Kaste M, et al. Predicting outcome of IV thrombolysis-treated ischemic stroke patients: the DRAGON score. Neurology. 2012;78:427-432.
7. Barber PA, Demchuk AM, Zhang J, Buchan AM. Validity and reliability of a quantitative computed tomography score in predicting outcome of hyperacute stroke before thrombolytic therapy. ASPECTS Study Group. Alberta Stroke Programme Early CT Score. Lancet. 2000;355:1670-1674.
8. Barber PA, Hill MD, Eliasziw M, Demchuk AM, Pexman JH, Hudon ME, et al.; ASPECTS Study Group. Imaging of the brain in acute ischaemic stroke: comparison of computed tomography and magnetic resonance diffusion-weighted imaging. J Neurol Neurosurg Psychiatr. 2005;76:1528-1533.
9. Tei H, Uchiyama S, Usui T, Ohara K. Diffusion-weighted ASPECTS as an independent marker for predicting functional outcome. J Neurol. 2011;258:559-565.
10. Dennis M, Mead G, Doubal F, Graham C. Determining the modifed Rankin score after stroke by postal and telephone questionnaires. Stroke. 2012;43:851-853.
11. Lin K, Lee SA, Zink WE. What ASPECTS value best predicts the 100mL threshold on diffusion weighted imaging? Study of 150 patients with middle cerebral artery stroke. J Neuroimaging. 2011;21:229-231.
12. Broderick JP. Endovascular therapy for acute ischemic stroke. Stroke. 2009;40:S103-S106.
13. Nezu T, Koga M, Kimura K, Shiokawa Y, Nakagawara J, Furui E, et al. Pretreatment ASPECTS on DWI predicts 3-month outcome following rt-PA: SAMURAI rt-PA Registry. Neurology. 2010;75:555-561.
14. Demchuk AM, Hill MD, Barber PA, Silver B, Patel SC, Levine SR; NINDS rtPA Stroke Study Group, NIH. Importance of early ischemic computed tomography changes using ASPECTS in NINDS rtPA Stroke Study. Stroke. 2005;36:2110-2115.
15. Kimura K, Sakamoto Y, Iguchi Y, Shibazaki K. Clinical and MRI scale to predict very poor outcome in tissue plasminogen activator patients. Eur Neurol. 2011;65:291-295.
16. Aries MJ, Uyttenboogaart M, Koopman K, Rödiger LA, Vroomen PC, De Keyser J, et al. Hyperdense middle cerebral artery sign and outcome after intravenous thrombolysis for acute ischemic stroke. J Neurol Sci. 2009;285:114-117.
17. Rubiera M, Ribo M, Delgado-Mederos R, Santamarina E, Delgado P, Montaner J, et al. Tandem internal carotid artery/middle cerebral artery occlusion: an independent predictor of poor outcome after systemic thrombolysis. Stroke. 2006;37:2301-2305.
18. Lou M, Safdar A, Mehdiratta M, Kumar S, Schlaug G, Caplan L, et al. The HAT Score: a simple grading scale for predicting hemorrhage after thrombolysis. Neurology. 2008;71:1417-1423.
19. Saposnik G, Fang J, Kapral MK, Tu JV, Mamdani M, Austin P, et al.; Investigators of the Registry of the Canadian Stroke Network (RCSN); Stroke Outcomes Research Canada (SORCan) Working Group. The iScore predicts effectiveness of thrombolytic therapy for acute ischemic stroke. Stroke. 2012;43:1315-1322.
20. Kent DM, Selker HP, Ruthazer R, Bluhmki E, Hacke W. The stroke-thrombolytic predictive instrument: a predictive instrument for intravenous thrombolysis in acute ischemic stroke. Stroke. 2006;37:2957-2962.
21. Ntaios G, Faouzi M, Ferrari J, Lang W, Vemmos K, Michel P. An integer-based score to predict functional outcome in acute ischemic stroke: the ASTRAL score. Neurology. 2012;78:1916-1922.
22. Tei H, Uchiyama S, Usui T, Ohara K. Posterior circulation ASPECTS on diffusion-weighted MRI can be a powerful marker for predicting functional outcome. J Neurol. 2010;257:767-773.